Search Results - "Wolfromm, A"

Lymphomas: A therapeutic update by Wolfromm, A, Delarue, R

“…Emergence of new molecules has considerably reshaped the management of patients in onco-hematology. Cytotoxic chemotherapy has not been altered, and CHOP…”
Get full text

Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia by Lainey, E, Wolfromm, A, Marie, N, Enot, D, Scoazec, M, Bouteloup, C, Leroy, C, Micol, J-B, De Botton, S, Galluzzi, L, Fenaux, P, Kroemer, G

“…The term myelodysplastic syndrome (MDS) identifies a heterogeneous group of clonal disorders originating from bone marrow stem cells that often progress to…”
Get full text

KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA by Cheminant, M., Carras, S., Bruneau, J., Lemonnier, F., Bachy, E., Herbaux, C., Feugier, P., Daguindau, N., Gastinne, T., Guillermin, Y., Lamarque, M., Slama, B., Wolfromm, A., Morschhauser, F., Tournilhac, O., Gaulard, P., Asnafi, V., Ortonne, N., Damaj, G., Hermine, O.

Get full text

CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY FOLLICULAR HELPER T‐CELL LYMPHOMA: AN ANCILLARY STUDY OF THE ORACLE TRIAL, A LYSA STUDY by Loyaux, R., Sako, N., Quang, V. Tran, Bachy, E., Morschhauser, F., Cartron, G., Gressin, R., Daguindau, N., Le Gouill, S., Wolfromm, A., Bouabdallah, K., Ysebaert, L., Casasnovas, O., Robe, C., Delfau, M., Dupuis, J., Leval, L., Gaulard, P., Sloma, I., Lemonnier, F.

Get full text

Painful ophthalmoplegia in a patient with a history of marginal zone lymphoma by Van Bogaert, C., Mathey, C., Vierasu, I., Trotta, N., Rocq, L., Wolfromm, A., De Wilde, V., Goldman, S.

“…A 73-year-old man with a history of marginal zone lymphoma was admitted to the emergency room for diplopia and ipsilateral headache. The…”
Get full text

106 Treatment of advanced CMML by azacitidine (AZA) in a compassionate program. The GFM experience in 38 patients (pts) by Wolfromm, A, Dreyfus, F, Vey, N, Delaunay, J, Stamatoullas, A, Banos, A, Marfaing-Koka, A, De Botton, S, Bordessoule, D, Legros, L, Rauzy, O. Beynes, Gyan, E, Makhoul, P. Cony, Thepot, S, Itzykson, R, Fenaux, P, Ades, L

Get full text

Management of thrombocytopenia by Wolfromm, A, Dallemagne, J

“…Thrombocytopenia is defined by a platelet level below 150 G/l. However, the limit of 100 G/l seems more appropriate to determine which thrombocytopenia will…”
Get full text

Actualités thérapeutiques dans les lymphomes by Wolfromm, A., Delarue, R.

“…L’émergence de nouvelles molécules a considérablement remodelé la prise en charge des patients en onco-hématologie. Les chimiothérapies cytotoxiques n’ont pas…”
Get full text